Effects of zoledronate on bone mineral density and bone turnover after long-term denosumab therapy: Observations in a real-world setting

Vertebral fracture assessment using a semiquantitative technique

Harry K. Genant, Chun‐Ying Wu, Cornelis van Kuijk et al. · Journal of Bone and Mineral Research · 1993 · 3.7K citations

Medicine, Orthopaedic Surgery, Radiology +13

Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension

Steven R. Cummings, Serge Ferrari, Richard Eastell et al. · Journal of Bone and Mineral Research · 2017 · 709 citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +16

Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass

Henry G. Bone, Michael A. Bolognese, Chui Kin Yuen et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 611 citations

Medicine, Endocrinology, Bone Metabolism +16

Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial

Paul D. Miller, Michael A. Bolognese, E. Michael Lewiecki et al. · Bone · 2008 · 574 citations

Medicine, Clinical Sciences, Endocrinology +17

RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass

Nicolas Bonnet, Lucie Bourgoin, Emmanuel Biver et al. · Journal of Clinical Investigation · 2019 · 305 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17